US Market Overview for Urological Devices 2016 - MedView
The urological device market is a well-established, relatively commoditized market. However, there are a few exceptions to this. In particular, this report examines recent innovations that aim to bring minimally invasive methodology, and low tissue damage procedures to benign prostatic hyperplasia (BPH) devices. Over the forecast period, the urology device market is expected to experience steady growth. Although a multitude of factors influence this growth, the socio-economic factors (obesity and age) facing the U.S. function as the dominant driver to this growth. Other major drivers for this market are an aging population, increasing medical coverage and a changing industry preference for high quality, single-use devices. Much of the urological device market is well established. This limits significant changes in average selling prices (ASP). However, recent regulations have forced hospitals and manufacturers to be wary of the potential for contamination of reusable units. This relation of reimbursement to infection rates is driving the disposable, single-use market. Single-use units traditionally have a higher per use cost, thereby driving up the overall market for many urological segments.The U.S. urological market includes devices for urinary incontinence, stone management, BPH (benign prostate hyperplasia) treatment devices, urological endoscopes, prostate cancer, urodynamic equipment, nephrostomy and erectile dysfunction. Although yet to be observed, an expected influencer of the urological device market is the shift of urologists from private practice to hospital settings. This movement has been anticipated for the past several years; however, any shift that has occurred to this date has been minimal. Over the forecast period, this shift is expected to play a critical role in the urological device market.